This topic contains a solution. Click here to go to the answer

Author Question: Recent research gave participants __________ to reduce people's feelings of social pain. A) a ... (Read 102 times)

rmenurse

  • Hero Member
  • *****
  • Posts: 513
Recent research gave participants __________ to reduce people's feelings of social pain.
 
  A) a shock
  B) a hug
  C) Tylenol
  D) Morphine

Question 2

PET scan and fMRI imaging show that pain stimuli activate which parts of the brain?
 
  A) The primary and secondary somatosensory cortices
  B) The primary somatosensory cortex and thalamus
  C) The anterior cingulate cortex and the cerebellum
  D) Many areas of the brain, including all of these



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

asware1

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

C

Answer to Question 2

D




rmenurse

  • Member
  • Posts: 513
Reply 2 on: Jun 21, 2018
Gracias!


ASDFGJLO

  • Member
  • Posts: 335
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library